Hi @Lurcher.A,
I read it as being for the first time ever, meaning such an outcome has never been achieved by a drug treatment, in trials. Otherwise I think the language should have been specific to the comparison between BTX 1308 and the placebo.
I think the reference (screenshot below) to the p38 MAP Kinase pathway, which pharmaceutical companies have been unsuccessful in targeting over many years, strongly supports that interpretation.
I'm actually pretty confident that is what they mean, but we'll see.
That is a simple clarification to get from Matt, for the people who are in touch with him.
Cheers.
Hi @Lurcher.A, I read it as being for the first time ever,...
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
29.0¢ |
Change
0.015(5.45%) |
Mkt cap ! $456.7M | |||
| Open | High | Low | Value | Volume |
| 28.0¢ | 29.0¢ | 27.5¢ | $869.9K | 3.051M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 222976 | 28.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 29.0¢ | 14814 | 1 |
View Market Depth
| Last trade - 16.10pm 29/05/2024 (20 minute delay) ? |
|
|||||
|
Last
29.0¢ |
Change
0.015 ( 3.65 %) |
||||
| Open | High | Low | Volume | ||
| 28.0¢ | 29.0¢ | 28.0¢ | 941972 | ||
| Last updated 15.59pm 29/05/2024 ? | |||||
| BOT (ASX) Chart |